BioCryst Pharmaceuticals
BCRX
#4883
Rank
NZ$3.52 B
Marketcap
NZ$13.70
Share price
0.79%
Change (1 day)
7.06%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): NZ-$2.01

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$2.57. In 2022 the company made an earnings per share (EPS) of NZ-$2.37 a decrease over its 2021 EPS that were of NZ-$1.83.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$2.01-14.97%
2022NZ-$2.3729.13%
2021NZ-$1.83-4.63%
2020NZ-$1.9210.2%
2019NZ-$1.750%
2018NZ-$1.7525.64%
2017NZ-$1.394%
2016NZ-$1.3427.12%
2015NZ-$1.05-13.24%
2014NZ-$1.2123.64%
2013NZ-$0.98-30.38%
2012NZ-$1.41-37.3%
2011NZ-$2.2465.79%
2010NZ-$1.35117.14%
2009NZ-$0.62-46.15%
2008NZ-$1.16-26.97%
2007NZ-$1.59-40.67%
2006NZ-$2.6748.51%
2005NZ-$1.801%
2004NZ-$1.7838.89%
2003NZ-$1.28-25%
2002NZ-$1.71231.03%
2001NZ-$0.52-56.72%
2000NZ-$1.1991.43%
1999NZ-$0.622.94%
1998NZ-$0.61-55.84%
1997NZ-$1.3711.59%
1996NZ-$1.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ-$5.52 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.13-299.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ-$4.69 82.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ-$0.36-86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ-$2.71 5.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.75 202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ-$0.78-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$5.66 120.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$6.13 138.89%๐Ÿ‡บ๐Ÿ‡ธ USA